Article Information
History
- August 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- H. David Humes, MD1,2,*,
- Keith D. Aaronson, MD, MS1,
- Deborah Buffington, BS1,
- Hani N. Sabbah, PhD3,
- Angela J. Westover, BS1,2,
- Lenar T. Yessayan, MD,MS1,
- Balazs Szamosfalvi, MD1 and
- Francis D. Pagani, MD, PhD4
- 1Department of Internal Medicine, University of Michigan; Ann Arbor, Michigan
- 2Innovative Biotherapies; Ann Arbor, Michigan
- 3Department of Medicine; Henry Ford Hospital, Detroit, Michigan
- 4Department of Cardiovascular Surgery; University of Michigan, Ann Arbor, Michigan
- ↵*Corresponding Author: dhumes{at}umich.edu. H. David Humes, 1150 W Medical Center Drive, University of Michigan, Ann Arbor, MI 48109
Posted August 21, 2022.
Translation of Immunomodulatory Therapy to Treat Chronic Heart Failure: Preclinical Studies to First in Human
